ArticleBioMed research international2019

A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line.

Thandi Mqoco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.